High-risk R/R LBCL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors. (NCT07538635) | Zhejiang Cancer Hospital | 2026-04-20 |
Track High-risk R/R LBCL automatically
Every clearance here is in the API, with alerts when new ones post.